You are here

  • Home
  • Archive
  • Volume 3, Issue 11
  • Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study

Article metrics

Article menu
XML
Epidemiology
Research
Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201825192
Feb 2018262411
Mar 201843406
Apr 201822160
May 2018433911
Jun 201850366
Jul 201846422
Aug 201837374
Sep 201841413
Oct 201852526
Nov 201840403
Dec 201833335
Jan 2019474711
Feb 2019464715
Mar 201960608
Apr 2019757511
May 2019676714
Jun 2019444415
Jul 201934348
Aug 201926265
Oct 201954519
Nov 201938385
Dec 2019505013
Jan 202039399
Feb 202031304
Mar 202029272
May 202012123
Jun 202026267
Jul 2020191910
Aug 2020313111
Sep 2020363612
Oct 202051477
Nov 202023194
Dec 202036322
Jan 2021272714
Feb 202137376
Mar 202131317
Apr 202130308
May 2021282011
Jun 202110105
Jul 202122224
Aug 202114147
Sep 202129287
Oct 2021232325
Nov 2021141218
Dec 202114143
Jan 202233299
Feb 2022373712
Mar 202224275
Apr 202215157
May 202212126
Jun 2022312311
Jul 202217178
Aug 2022232217
Sep 2022151610
Oct 202224148
Nov 2022272513
Dec 202215133
Jan 202323224
Feb 202318166
Mar 202320191
Apr 2023201410
May 2023252514
Jun 202324152
Jul 2023403914
Aug 202311116
Sep 202313131
Oct 2023595912
Nov 20231631435
Dec 202338263
Jan 2024992
Feb 202415156
Mar 202432309
Apr 202415124
Total24092262567